False Data and Last Hopes
Enrolling Ineligible Patients in Clinical Trials
Bibliographic Data
| ID | 20337298 |
|---|---|
| Authors | Harold Y Vanderpool (Cal Humanities), Gary B Weiss (The University of Texas Medical Branch at Galveston) |
| Year | 1987 |
| Volume | 17 |
| Issue | 2 |
| Pages | 16 |
| Publication date | 1987-04-01 |
| Open Access | No |
| Type | ARTICLE |
| Venue | The Hastings Center Report (JOURNAL) |
| Journal identifiers | ISSN: 0093-0334 • E-ISSN: 1552-146X |
| Publisher | JSTOR (PUBLISHER) |
| DOI | 10.2307/3562037 |
| PMID | 3294742 |
| OpenAlex | W1572008663 |
| Language | EN |
| Citations received | 5 |
A persistent ethical dilemma in research is the potential conflict between the patient-subject's best interests and the principles of scientific methodology. Vanderpool and Weiss discuss the problem in cancer research when a physician falsifies data in order to increase a patient's chances of being selected to participate in a clinical trial. While raising the question of whether such lying is justified if it may prolong the life of a cancer patient for whom there are no other therapeutic options, the authors point out that the inclusion of ineligible subjects may render trial results invalid
Clinical trial · Dilemma · Epistemology · Inclusion (mineral) · Order (exchange) · Pathology · Subject (documents) · Biomedical Ethics and Regulation · Computer Science · Ethics in Clinical Research · Ethics in medical practice · Medicine · Philosophy · Psychology · Social Psychology
The conflicting roles of clinicians versus investigators in HIV randomised clinical trials
Communication and Miscommunication in Informed Consent to Research
Bounty-Hunting and Finder's Fees
Nonvalidated Therapies and HIV Disease
Is it any good? The evaluation of therapy by participants in a clinical trial
| Citations per year | 0.14 |
|---|---|
| Citation span | 1989 - 2005 (17) |
| Highly cited | No |